Correction to: Therapeutic novelties in migraine: new drugs, new hope?

  • Thien Phu Do
  • Song Guo
  • Messoud AshinaEmail author
Open Access

Correction to: J Headache Pain (2019) 20:37

After publication of the original article [1], the authors have notified us that the row corresponding to the “Alniditan” drug shouldn’t have been included in Table 1. Table 1 should therefore be presented as below:
Table 1

Overview of ditans in alphabetical order



Lasmiditan (COL-144)

Phase III clinical trials


Development terminated


  1. 1.
    Do TP et al (2019) Therapeutic novelties in migraine: new drugs, new hope? J Headache Pain 20:37. CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  1. 1.Danish Headache Center and Department of Neurology, Rigshospitalet Glostrup, Faculty of Health SciencesUniversity of CopenhagenCopenhagenDenmark

Personalised recommendations